Skip to main content
Log in

Serum Vitamin D Levels in Indian Patients with Multiple Sclerosis

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Low serum vitamin D level has an increased association with risk of multiple sclerosis (MS).There has been no published data on the levels of this vitamin in Indian population with MS. Hence we decided to undertake this study to document if there is evidence of vitamin D deficiency in patients with MS in our population. 26 patients with diagnosis of MS by modified Mc Donald’s criteria were enrolled in this study. Serum vitamin D (1,25 hydroxy) levels were measured by electro-chemiluminescence in our biochemistry lab. An age-matched control group of 202 patients who did not have a diagnosis of MS were included. In our study group 76.9 % had vitamin D level less than 20 ng/ml compared to 65.5 % of control group (p value of 0.019). Our study revealed a trend towards low vitamin D values in Indian MS patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kurtzke JF. Geography in multiple sclerosis. J Neurol. 1977;215:1–26.

    Article  PubMed  CAS  Google Scholar 

  2. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988;67:373–8.

    Article  PubMed  CAS  Google Scholar 

  3. Ladizesky M, Lu Z, Oliveri B, San RN, Diaz S, Holick MF, Ladizesky M, Lu Z, Oliveri B, San RN, Diaz S, Holick MF, et al. Solar ultraviolet B radiation an photo production of vitamin D3 in central and southern areas of Argentina. J Bone Miner Res. 1995;10:545–9.

    Article  PubMed  CAS  Google Scholar 

  4. Cosman F, Nieves J, Herbert J, Shen V, Lindsay R. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton. J Bone Miner Res. 1994;9:1097–105.

    Article  PubMed  CAS  Google Scholar 

  5. Nieves J, Cosman F, Herbert J, Shen V, Lindsay R. High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology. 1994;44:1687–92.

    Article  PubMed  CAS  Google Scholar 

  6. Auer DP, Schumann EM, Kumpfel T, Gossl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesion in multiple sclerosis. Ann Neurol. 2000;47:276–7.

    Article  PubMed  CAS  Google Scholar 

  7. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuation of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;48:271–2.

    Article  PubMed  CAS  Google Scholar 

  8. Simpson S Jr, Taylor B, Blizzard L. Higher 25-hydroxyl vitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol. 2010;68(2):193–203.

    PubMed  CAS  Google Scholar 

  9. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010;67(5):618–24.

    PubMed  CAS  Google Scholar 

  10. Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132(5):1146–60.

    Article  PubMed  Google Scholar 

  11. Smolders J. Vitamin D as an immunomodulator in Multiple sclerosis. J Neuroimmunol. 2008;194:7–17.

    Article  PubMed  CAS  Google Scholar 

  12. Acheson ED, Bachrach CA, Wright FM. Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation and other variables. Acta Psychiatr Scand. 1960;35(suppl 147):132–47.

    Article  CAS  Google Scholar 

  13. Sutherland JM, Tyrer JH, Eadie MJ. The prevalence of multiple sclerosis in Australia. Brain. 1962;85:146–64.

    Article  Google Scholar 

  14. Leibowitz U, Sharon D, Alter M. Geographical considerations in multiple sclerosis. Brain. 1967;90:871–86.

    Article  PubMed  CAS  Google Scholar 

  15. Kurtzke JF. On the fine structure of the distribution of multiple sclerosis. Acta Neurol Scand. 1967;43:257–82.

    Article  PubMed  CAS  Google Scholar 

  16. Geiger R. The climate near the ground. Cambridge: Harvard University Press; 1965. p. 442–6.

    Google Scholar 

  17. Presthus J. Report on the multiple sclerosis investigations in West Norway. Acta Psychiatr Neurol Scand. 1960;35(Suppl 147):88–92.

    Article  CAS  Google Scholar 

  18. Westlund K. Distribution and mortality time trend of multiple sclerosis and some other diseases of Norway. Acta Neurol Scand. 1970;46:455–83.

    Article  PubMed  CAS  Google Scholar 

  19. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-Hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–8.

    Article  PubMed  CAS  Google Scholar 

  20. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler. 2008;14(9):1220–4.

    Article  PubMed  CAS  Google Scholar 

  21. Van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581–90.

    Article  PubMed  Google Scholar 

  22. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler. 2005;11(3):266–71.

    Article  PubMed  Google Scholar 

  23. Soilu-Hänninen M, Laaksonen M, Laitinen I, Erälinna JP, Lilius EM, Mononen I. A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis. J Neurol Neurosurg Psychiatr. 2008;79(2):152–7.

    Article  PubMed  Google Scholar 

  24. Auer DP, Schumann EM, Kümpfel T, Gössl C, Trenkwalder C. Seasonal fluctuations of gadolinium-enhancin magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;47(2):276–7.

    Article  PubMed  CAS  Google Scholar 

  25. Smolders J, Mariëlle T, Evelyn P, Paul M, Jan WCT, Jan D, et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE. 2009;4(8):e6635.

    Article  PubMed  Google Scholar 

  26. Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, et al. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler. 2009;15(11):1280–5.

    Article  PubMed  Google Scholar 

  27. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch H-M, Thibault L, et al. A Phase I/II dose-escalation trial of oral vitamin D3 with calcium supplementation in patients with multiple sclerosis. Mult Scler. 2008;14(Suppl 1):S34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Radhakrishnan Suresh Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Suresh Kumar, R., Syed, S., Anand Kumar, A. et al. Serum Vitamin D Levels in Indian Patients with Multiple Sclerosis. Ind J Clin Biochem 28, 255–258 (2013). https://doi.org/10.1007/s12291-012-0264-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-012-0264-1

Keywords

Navigation